Literature DB >> 21057142

Hypoalbuminemia in critically ill patients with cancer: incidence and mortality.

Silvio A Ñamendys-Silva1, María O González-Herrera, Julia Texcocano-Becerra, Angel Herrera-Gómez.   

Abstract

PURPOSE: The aim of this study was to investigate the incidence of hypoalbuminemia in critically ill patients with cancer and to describe the relationship of serum albumin levels to mortality.
DESIGN: An observational cohort study. There were no interventions.
RESULTS: During the study period, 200 patients were eligible for inclusion. A total of 164 (82%) patients had a serum albumin concentration below 35 g/L, of which 91 (55.5%) patients had levels of albumin ≤20 g/L. The mean serum albumin was 18.17 g/L. The crude mortality rate was 22.5%. The highest mortality rate (73%) was seen in the group of patients whose serum albumin levels were <20 g/L.
CONCLUSION: The incidence of hypoalbuminemia in critically ill patients with cancer admitted to ICU was high.

Entities:  

Mesh:

Year:  2010        PMID: 21057142     DOI: 10.1177/1049909110384841

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  12 in total

1.  The clinical relevance of plasma protein binding changes.

Authors:  Jason A Roberts; Federico Pea; Jeffrey Lipman
Journal:  Clin Pharmacokinet       Date:  2013-01       Impact factor: 6.447

Review 2.  Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Authors:  Jochen Schacht; Andra E Talaska; Leonard P Rybak
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

Review 3.  Albumin administration in the acutely ill: what is new and where next?

Authors:  Jean-Louis Vincent; James A Russell; Matthias Jacob; Greg Martin; Bertrand Guidet; Jan Wernerman; Ricard Ferrer; Ricard Ferrer Roca; Stuart A McCluskey; Luciano Gattinoni
Journal:  Crit Care       Date:  2014-07-16       Impact factor: 9.097

4.  A practical scoring system to predict mortality in patients with perforated peptic ulcer.

Authors:  Ebru Menekse; Belma Kocer; Ramazan Topcu; Aydemir Olmez; Mesut Tez; Cuneyt Kayaalp
Journal:  World J Emerg Surg       Date:  2015-02-21       Impact factor: 5.469

5.  Hypoalbuminemia is a strong predictor of 30-day all-cause mortality in acutely admitted medical patients: a prospective, observational, cohort study.

Authors:  Marlene Ersgaard Jellinge; Daniel Pilsgaard Henriksen; Peter Hallas; Mikkel Brabrand
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

6.  U-shape association of serum albumin level and acute kidney injury risk in hospitalized patients.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Michael A Mao; Ankit Sakhuja; Kianoush Kashani
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

7.  Clinical predictive factors of long-term survival after curative resection of pancreatic cancer: a retrospective study.

Authors:  Yutaka Nakano; Minoru Kitago; Masahiro Shinoda; Yuta Abe; Hiroshi Yagi; Taizo Hibi; Ayano Takeuchi; Koichi Aiura; Osamu Itano; Yuko Kitagawa
Journal:  Cancer Med       Date:  2017-09-18       Impact factor: 4.452

8.  Verification of serum albumin elevating effect of cell-free and concentrated ascites reinfusion therapy for ascites patients: a retrospective controlled cohort study.

Authors:  Yosuke Yamada; Keita Inui; Yuuta Hara; Kazuaki Fuji; Kosuke Sonoda; Koji Hashimoto; Yuji Kamijo
Journal:  Sci Rep       Date:  2019-07-15       Impact factor: 4.379

9.  Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery.

Authors:  Wei-Ru Cho; Chao-Hung Hung; Chien-Hung Chen; Chih-Che Lin; Chih-Chi Wang; Yueh-Wei Liu; Yi-Ju Wu; Chee-Chien Yong; Kuang-Den Chen; Yu-Chieh Tsai; Tsung-Hui Hu; Ming-Chao Tsai
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

10.  The Neutrophil Percentage-to-Albumin Ratio Is Associated with All-Cause Mortality in Critically Ill Patients with Acute Kidney Injury.

Authors:  Benji Wang; Diwen Li; Bihuan Cheng; Binyu Ying; Yuqiang Gong
Journal:  Biomed Res Int       Date:  2020-02-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.